doi: 10.3390/medicina59101769
The Medicaid Debate: Should GLP-1 Drugs Be Covered
Joseph Volpicelli, who was part of some of the earliest clinical research on naltrexone for alcohol dependence, describes the mechanism this way: Naltrexone works by blocking the receptors in the brain that register the feelings of reward and pleasure that many feel from alcohol consumption. In practical terms, alcohol still reaches the brain, but the reinforcement signal becomes weaker
In addition to chronic weight management, Wegovy is also approved to lower the risk of cardiovascular death, heart attacks, and stroke in people who are obese or overweight with heart disease
Insulin is super important because its like a delivery van for sugar
Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and non-diabetic patients